Big day for AI in bio: OpenAI-Orchestra Bio deal, Holon-S1 cancer model, more
iScienceLuvr · x · 2026-10-21
iScienceLuvr rounds up a busy day for AI in bio: OpenAI's acquisition of Orchestra Bio, Anthropic's anti-scorpion neurotoxin research, a new model from Radical Numerics, and Sophont AI's Holon-S1 cancer biology model, which he calls the best of all.
More from Venture
- What Would a High-Margin LLM Business Look Like When Everyone Bills by Token? — WholeOrganization915 · 2026-10-21
- Confidential Inference quietly grows as onchain AI workloads demand privacy — 0xJeff · 2026-10-21
- YC-Backed Manufacturing Startup Nox Metals Hits $25M Annualized Revenue in Under a Year — ycombinator · 2026-10-21
- Nvidia's $12.9B Hugging Face acquisition is its largest ever — FinanceYF5 · 2026-10-21
- 8 US cybersecurity giants each bought an AI-native firewall startup in two years — FinanceYF5 · 2026-10-21
- Why OpenRouter is worth $7.5B: a 5.5% toll on every model API call — FinanceYF5 · 2026-10-21